Karl-Johan Malmberg, Director, Center of Excellence: Precision Immunotherapy Alliance at The University of Oslo, shared a post on LinkedIn:
“Amazing news coming in just before the holidays. Continued support for our basic NK cell research from Norges forskningsråd.
This work is co-lead by Santosh Phuyal and Lamberto Torralba-Raga, Ph.D. and involves in depth studies of organelle biologi and synthetic receptor engineering in NK cells.
More from Karl-Johan Malmberg.